Overcoming the Challenges in Targeting Low Tumor Mutational Burden Cancers for Improved Therapies
Time: 11:30 am
day: Conference Day Two
Details:
- Utilizing neoantigen personalized vaccines in lung, breast, and colorectal cancers to evoke an immune response
- Examining the clinical efficacy of cancer indications with low tumor burden to highlight the therapeutic impact of personalized cancer vaccines
- Overcoming difficulties in treating low tumor mutational burdens in cancers using dendritic cell-based personalized cancer vaccines that show clinical efficacy
